Web-based validation, as analyzed by UALCAN, was utilized to identify potential biomarkers, including six remarkable proteins that were up-regulated in the uEVs of the BC patients: periostin, ATAD2, BCAS4, GSK3β, HK1, and Ki-67. Here, MKI67 is linked to breast cancer.